News from insmed incorporated A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 16, 2012, 08:00 ET Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced the appointments of Donald J. Hayden, Jr. as Executive Chairman...


May 08, 2012, 07:00 ET Insmed Announces First Quarter 2012 Financial Results

Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2012. Key Recent...


May 07, 2012, 08:00 ET Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has lifted the...


Apr 24, 2012, 08:00 ET Insmed to Host 2012 First Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Tuesday, May 8th, 2012, at 8:30 AM ET, to discuss...


Apr 16, 2012, 08:00 ET Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced the initiation of the Company's CLinical Evaluation of ARIKACE...


Mar 13, 2012, 07:00 ET Insmed Announces Fourth Quarter and Full-Year 2011 Financial Results

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the fourth quarter and fiscal year ended December 31,...


Feb 28, 2012, 08:00 ET Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Tuesday, March 13th, 2012, at 8:30 AM ET, to...


Feb 10, 2012, 08:00 ET Insmed Incorporated Provides Update on Clinical Program for ARIKACE®

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the Company is proceeding with a phase 2 clinical trial of...


Jan 20, 2012, 08:00 ET Insmed Incorporated Provides Corporate Update

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has lifted the...


Nov 14, 2011, 08:00 ET Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that Timothy Whitten, President and CEO of Insmed, will be...


Nov 08, 2011, 07:00 ET Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2011

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported financial results for the third quarter and nine-months ended...


Oct 25, 2011, 08:00 ET Insmed to Host 2011 Third Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Tuesday, November 8th, 2011, at 8:30 AM ET, to...


Oct 14, 2011, 08:00 ET Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the Company has been notified by the U.S. Food and Drug...


Sep 26, 2011, 08:00 ET Insmed to Present at Sixth Annual JMP Securities Healthcare Conference

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that Timothy Whitten, President and CEO of Insmed, will be...


Aug 11, 2011, 08:00 ET Insmed to Present at 2011 Wedbush Securities Life Sciences Management Access Conference

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that Timothy Whitten, President and CEO of Insmed, will be...


Aug 08, 2011, 07:00 ET Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011. ...


Aug 01, 2011, 08:09 ET Insmed Incorporated Announces Clinical Hold on ARIKACE® Phase 3 Clinical Trials

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the ...


Jul 26, 2011, 08:00 ET Insmed to Host 2011 Second Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Monday, August 8th, 2011, at 8:30 AM ET, to...


Jul 18, 2011, 08:00 ET Andrea Drucker Joins Insmed as General Counsel

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that Andrea ("Andi") Holtzman Drucker, J.D. has been appointed to ...


Jun 28, 2011, 08:00 ET Insmed Announces its Addition to the Russell 3000® Index

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that it has been added to the Russell 3000® Index following...


Jun 10, 2011, 11:00 ET Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced positive data through six treatment cycles (72 weeks total...


May 10, 2011, 07:00 ET Insmed Announces First Quarter 2011 Financial Results

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2011. Key Recent...


Apr 26, 2011, 08:00 ET Insmed to Host 2011 First Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Tuesday, May 10th, 2011, at 8:30 AM ET, to discuss ...


Mar 21, 2011, 08:15 ET Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication

Insmed Incorporated (Nasdaq: INSMD), a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to...


Mar 21, 2011, 08:00 ET Insmed Regains NASDAQ Compliance

Insmed Incorporated (Nasdaq CM: INSMD), a biopharmaceutical company, today announced that it has received notification from The NASDAQ Stock Market...